GDRX Stock Analysis: Buy, Sell, or Hold?
GDRX - GoodRx Holdings, Inc. Class A Common Stock
$3.45
-0.11 (-3.09%)
âŧ
5d:
-7.51%
30d:
+20.21%
90d:
+34.77%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When GDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GDRX is fairly priced but lacks strong directional signals. At 11.8% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GDRX is fairly priced but lacks strong directional signals. At 11.8% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.12
Based on 10.9% avg growth
INTRINSIC VALUE TODAY
$2.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GDRX is currently trading at $3.45, which is considered fair relative to its 30-day fair value range of $3.02 to $3.61. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.7) compared to its historical average (6.9). At these levels, the market is pricing in 11.8% annual earnings growth.
Technical Outlook: Technically, GDRX is in a strong uptrend. The price is currently testing key support at $3.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: GDRX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.95 (+14.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GDRX is in a strong uptrend. The price is currently testing key support at $3.44. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: GDRX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.95 (+14.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.02 -
$3.61
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.2%
Protect Your Profits
Holding GDRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading below Wall St target ($3.95)
- BULLISH: Expecting earnings turnaround to 11.8% growth with -1.3% revenue growth
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.02 -
$3.61
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.44
Resistance Level
$3.89
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.65
Wall Street Target
$3.95
(+14.6%)
Revenue Growth (YoY)
-1.3%
Earnings Growth (YoY)
-44.5%
Profit Margin
2.1%
Valuation Premium vs History
+11.8% premium
PE vs Historical
9.7 vs 6.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.8%
(market-implied from PE analysis)
1-Year Target
$3.86
(+12%)
2-Year Target
$4.31
(+25%)
3-Year Target
$4.82
(+40%)
3-Yr Target (if PE normalizes)
(PE: 10â7)
PE COMPRESSION
$3.45
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 17.8%)
$11.72
(+240%)
Base:
(SPY PE: 9.7, Growth: 17.8%)
$5.63
(+63%)
Bear:
(PE: 6.9, Growth: 17.8%)
$4.03
(+17%)
đ
Valuation based on Current Earnings
Forward PE: 5.44 | Forward EPS (Implied): $0.63
Bull Case
$4.17
(+21%)
Analyst growth 15.0%, PE expands to 5.7
Base Case
$3.45
(0%)
Market implied 0.0%, PE stable at 5.4
Bear Case
$2.64
(-24%)
Severe decline -15.0%, PE contracts to 4.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 3:40 PM ET
Data refreshes hourly during market hours. Next update: 4:40 PM
Data refreshes hourly during market hours. Next update: 4:40 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
12 analysts |
$79 | 63 BUY |
Advanced GDRX Option Strategies
Professional options setups generated by AI based on today's GDRX price and gamma walls.
